Elvira Mustać

588 total citations
37 papers, 456 citations indexed

About

Elvira Mustać is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Elvira Mustać has authored 37 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Elvira Mustać's work include Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Elvira Mustać is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Elvira Mustać collaborates with scholars based in Croatia, Italy and United States. Elvira Mustać's co-authors include Nives Jonjić, Ita Hadžisejdić, Marija Petković, Blaženka Grahovac, Ksenija Lučin, Željko Fučkar, Gordana Đorđević, Ivana Marić, Josip Španjol and Sanja Štifter and has published in prestigious journals such as Journal of Clinical Microbiology, European Journal of Cancer and Modern Pathology.

In The Last Decade

Elvira Mustać

37 papers receiving 451 citations

Peers

Elvira Mustać
Comparison fields: 5 of 72
  • Molecular Biology 164
  • Oncology 152
  • Pulmonary and Respiratory Medicine 142
  • Cancer Research 113
  • Surgery 68
Replace Maria Gonidi with:
Maria Gonidi Greece
Pamela Sighinolfi Italy
Judy Walls United States
Pawan Upadhyay India
Gioacchino D’Ambrosio Italy
Ryan J. Bair United States
Yoshihisa Hama Japan
B.K. Amo-Takyi Germany
Barbas do Amaral Portugal
Maria Gonidi Greece View profile →
Citations per field, relative to Elvira Mustać
Elvira Mustać · 1×
Citations per year, relative to Elvira Mustać
Elvira Mustać · 1×

Countries citing papers authored by Elvira Mustać

Since Specialization
Citations

This map shows the geographic impact of Elvira Mustać's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elvira Mustać with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elvira Mustać more than expected).

Fields of papers citing papers by Elvira Mustać

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elvira Mustać. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elvira Mustać. The network helps show where Elvira Mustać may publish in the future.

Co-authorship network of co-authors of Elvira Mustać

This figure shows the co-authorship network connecting the top 25 collaborators of Elvira Mustać. A scholar is included among the top collaborators of Elvira Mustać based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elvira Mustać. Elvira Mustać is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 4
3 7
4
[Analysis of sentinel lymph node in early breast cancer patient - Clinical Hospital Center Rijeka].
1
5
[CLINICAL GUIDELINES FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH INVASIVE BREAST CANCER--CROATIAN ONCOLOGY SOCIETY].
1
6
INTERLABORATORY CONCORDANCE IN HER-2 POSITIVE BREAST CANCER.
2
7 21
8 17
9 10
10 7
11 16
12 66
13
"V"-technique as a method of breast conserving surgery in multifocal and T2 invasive breast cancers situated in the upper outer quadrant.
1
14
Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.
2
15 28
16 6
17 41
18 17
19 9
20 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026